Tau protein in normal and Alzheimer's disease brain

Journal of Alzheimer's Disease

Volumn 1, Issue 4-5, 1999, Pages 307-328

  Johnson, G V W ^a   Jenkins, S M ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Kinases; Oxidative stress; Pathology; Phosphatases; Phosphorylation

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN; PROTEIN KINASE; TAU PROTEIN;

ALZHEIMER DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROTUBULE ASSEMBLY; NEUROFIBRILLARY TANGLE; PAIRED HELICAL FILAMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MODIFICATION; PROTEIN PROCESSING; REVIEW;

EID: 0033302335     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-1999-14-511     Document Type: Review

References (188)

1. Microtubule-binding domain of tau proteins
2. Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease
3. Modulation of PHF-like tau phosphorylation in cultured neurones and transfected cells
4. Structure and novel exons of the human tau gene
5. Okadaic acid induces early changes in microtubule-associated protein 2 and tau phosphorylation prior to neurodegeneration in cultured cortical neurons
6. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
7. Abnormal phosphorylation of tau preceded ubiquitination in neurofibrillary pathology of Alzheimer disease
8. The amadori product on protein: Structure and reactions
9. Hydrogen peroxide mediates amyloid beta protein toxicity
10. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics
11. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding
12. The distribution of tau in the mammalian central nervous system
13. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects
14. Absence of abnormal hyperphosphorylation of tau in intracellular tangles in Alzheimer's disease
15. Presence of tau in isolated nuclei from human brain
16. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins)
17. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding
18. Interaction of tau with the neural plasma membrane mediated by tau'S amino-terminal projection domain
19. Alzheimer's disease and tau proteins
20. Taxol protects against calcium-mediated death of differentiated rat pheochromocytoma cells
21. Apoptosis and increased generation of reactive oxygen species in Down'S syndrome neurons in vitro
22. Tau protein binds to microtubules through a flexible array of distributed weak sites
23. Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons
24. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein
25. Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: Prevention by NGF and bFGF
26. Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin
27. Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly
28. Primary structure of high molecular weight tau present in the peripheral nervous system
29. Image reconstruction of the Alzheimer paired helical filament
30. Assembly of Alzheimer-like filaments from full-length tau protein
31. Differences in microtubule-binding and self-association abilities of bovine tau isoforms
32. Microfilament-associated growth cone component depends upon tau for its intracellular localization
33. Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau
34. Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state
35. Dephosphorylation of tau protein and Alzheimer paired helical filaments by calcineurin and phosphatase-2A
36. Microtubule-associated protein/microtubule affinity-regulating kinase (p110(mark) A novel protein kinase that regulates taumicrotubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262
37. Nerve growth factor-induced neurite outgrowth in PC12 cells involves the coordinate induction of microtubule assembly and assembly-promoting factors
38. Association of tau protein with microtubules in living cells
39. Tau protein function in living cells
40. Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of tau
41. Sense and antisense transfection analysis of tau function: Tau influences net microtubule assembly, neurite outgrowth and neuritic Stability
42. Ubiquitination
43. Modulation of the phosphorylation state of tau in situ: The roles of calcium and cyclic AMP
44. The ε-(γ-glutamyl)lysine crosslink and the catalytic role of transglutaminases
45. Ubiquitin: A multifunctional regulatory protein associated with the cytoskeleton
46. The cholinergic system in Alzheimer disease
47. Transglutaminase activity in rat brain: Characterization; Distribution, and changes with age
48. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: Differential expression of tau protein mRNAs in human brain
49. Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system
50. p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1. Implications for Alzheimer's disease
51. Tau protein and the neurofibrillary pathology of Alzheimer's disease
52. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: Identification of phosphorylation sites in tau protein
53. Phosphoprotein phosphatase activities in Alzheimer's disease brain
54. Dephosphorylation of microtubule-associated protein tau by protein phosphatase-1 and -2C and its implication in Alzheimer disease
55. Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau
56. Dephosphorylation of microtubule-associated protein 2, tau factor, and tubulin by calcineurin
57. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis
58. Casein kinase II preferentially phosphorylates human tau isoforms containing an amino-terminal insert, Identification of threonine 39 as the primary phosphate acceptor
59. Localization and in situ phosphorylation state of nuclear tau
60. A uniform isopeptide-linked multiubiquitin chain is sufficient to target substrate for degradation in ubiquitin-mediated proteolysis
61. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments
62. Abnormal phosphorylation of the microtubule-associated protein tau (τ) in Alzheimer cytoskeletal pathology
63. The Alzheimer-like phosphorylation of tau protein reduces microtubule binding and involves Ser-Pro and Thr-Pro motifs
64. Domains of tau protein and interactions with microtubules
65. Tau self-association: Stabilization with a chemical cross-linker and modulation by phosphorylation and oxidation state
66. Beta-Amyloi, protein processing and Alzheimer's disease
67. Tau protein becomes long and stiff upon phosphorylation: Correlation between paracrystalline structure and degree of phosphorylation
68. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase
69. Alzheimer's disease: The amyloid cascade hypothesis
70. Okadaic acid induces hyperphosphorylated forms of tau protein in human brain slices
71. Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain
72. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease
73. The ubiquitin system for protein degradation
74. Structure of the bovine tau gene: Alternatively spliced transcripts generate a protein family
75. Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains
76. Antibodies to paired helical filaments in Alzheimer's disease do not recognize normal brain proteins
77. Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease
78. Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments
79. Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filament
80. Mechanism of neurofibrillary degeneration in Alzheimer's disease
81. Alzheimer paired helical filaments: Restoration of biological activity by dephosphorylation
82. Inhibition of microtubule assembly by phosphorylation of microtubule-associated proteins
83. Differential phosphorylation of tau by cyclic AMP-dependent protein kinase and Ca2+/calmodulin-dependent protein kinase II: Metabolic and functional consequences
84. The crosslinking of tau into insoluble filaments by transglutaminase
85. Understanding the hyperphosphorylation of tau in Alzheimer's disease: Importance of examining site-specific phosphorylation in non-disease systems
86. Cholinergic muscarinic receptor signaling in Alzheimer's disease
87. Expression of multiple tau isoforms and microtubule bundle formation in fibroblasts transfected witH a single tau cDNA
88. Sorting mechanisms of tau and MAP2 in neurons: Suppressed axonal transit of MAP2 and locally regulated microtubule binding
89. Calcium ion induces endwise depolymerization of bovine brain microtubules
90. Protein kinase recognition sequence motifs
91. Paired helical filaments in electron microscopy of Alzheimer's Disease
92. Overexpression of tau in a nonneuronal cell induces long cellular processes
93. A cdc2-related kinase PSSALRE/cdk5 is homogenous with the 30kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtubules
94. Microtubule-associated protein tau: Abnormal phosphorylation of a nonpaired helical filament pool in Alzheimer disease
95. Microtubule-associated protein 2: Monoclonal antibodies demonstrate the selective incorporation of certain epitopes in Aizheimer neurofibrillary tangles
96. Microtubule-associated protein tau (τ) is a major antigenic component of paired helical filaments in Alzheimer disease
97. Developmentally regulated expression of specific tau sequences
98. Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease
99. Recognition of tau epitopes by antineurofilament antibodies that bind to Alzheimer neurofibrillary tangles
100. Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments
101. Stimulation of MAP kinase by v-raf transformation of fibroblasts fails to induce hyperphosphorylation of transfected tau
102. Analysis of microtubule-associated protein tau glycation in paired helical filaments
103. Isolation of a phosphorylated soluble tau fraction from Alzheimer's disease brain
104. Tau protein from Alzheimer's disease patients is glycated at its tubulin-binding domain
105. Role of glycation in aging
106. The primary structure and heterogeneity of tau protein from mouse brain
107. The microtubule binding domain of tau protein
108. Tau Protein: An update on structure and function
109. Expression of tau protein in non-neuronal cells: Microtubule binding and stabilization
110. A68: A major subunit of paired helical filaments and derivatized forms of normal tau
111. Identification of tau protein regions required for process formation in PC12 cells
112. Brain proline-directed protein kinase is a neurofilament kinase which displays high sequence homology to p34cdc2
113. A brain-specific activator of cyclin-dependent kinase 5
114. Neuronal cdc2-like kinase
115. The purification of tau protein and the occurrence of two phosphorylation states of tau protein and the occurrence of two phosphorylation states of tau in brain
116. Phosphorylation affects the ability of tau protein to promote microtubule assembly
117. Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain
118. Phosphorylation of tau in situ: Inhibition of calcium-dependent proteolysis
119. Abnormal tau proteins from Alzheimer's disease brains, Purification and amino acid analysis
120. Detection of a cdc2-related kinase associated with Alzheimer paired helical filaments
121. Identification of nuclear tau isoforms in human neuroblastoma cells
122. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells
123. Functional studies of Alzheimer's disease tau protein
124. Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau
125. Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases
126. Biopsy-derived adult human-brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau
127. b-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excito toxicity
128. Monoclonal antibodies with selective specificity for Alzheimer tau are directed against phosphatase-sensitive epitopes
129. Differential sensitivity to proteolysis by brain calpain of adult human tau, fetal human tau and PHF-tau
130. Paired helical filaments and the cytoplasmic-nuclear interface in Alzheimer's disease
131. Transglutaminase and the neuronal cytoskeleton in Alzheimer's disease
132. Transglutaminase cross-linking of the tan protein
133. Ubiquitin is a component of paired helical filaments in Alzheimer's disease
134. Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments
135. Proline-directed and non-proline-directed phosphorylation of PHF-tau
136. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors
137. Role of neurotransmission in the regulation of amyloid beta-protein precursor processing
138. Down'S syndrome: Up-regulation of beta-amyloid protein precursor and tan mRNAs and their defective coordination
139. Phosphorylation determines two distinct species of Tau in the central nervous system
140. Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tan associated with Alzheimer's paired helical filaments
141. Expression of protein phosphatases (PP-1, PP-2A, PP-2B and PTP-1B) and protein kinases (MAP kinase and P34cdc2) in the hippocampus of patients with Alzheimer disease and normal aged individuals
142. Transglutaminase C in cerebellar granule neurons: Regulation and localization of substrate crosslinking
143. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease
144. Multisite phosphorylation of tau proteins from rat brain
145. Cholinergic dysfunction in Alzheimer disease: Cause or effect?
146. Cell cycle-dependent phosphorylation and microtubule binding of tau protein stably transfected into Chinese hamster ovary cells
147. Proteolysis of mitochondria in reticulocytes during maturation is ubiqutin-dependent and is accompanied by a high rate of ATP hydrolysis
148. Update on cholinergic enhancement therapy for Alzheimer disease
149. Ubiquitin-mediated pathways for intracellular proteolysis
150. Natural substrates of the ubiquitin proteolytic pathway
151. The relationship between quantitative measures of dementia and of degenerative changes in the cerebral grey matter of elderly subjects
152. Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for b-structure
153. Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments
154. Alzheimer's disease: Insolubility of partially purified paired helical filaments in sodium dodecyl sulfate and urea
155. Brain transglutaminase: In vitro crosslinking of human neurofilament proteins into insoluble polymers
156. Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau
157. Radical AGEing in Alzheimer's disease
158. Glycogen synthase kinase-3β phosphorylates tau protein at multiple sites in intact cells
159. Phosphorylation of microtubule-associated protein tau: Identification of the site for Ca2(+)-calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles
160. Aberrant neurofilament phosphorylation in Alzheimer disease
161. Recognition of the minimal epitope of monoclonal antibody Tau-1 depends upon the presence of a phosphate group but not its location
162. Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type
163. The fine structure of neurofibrillary tangles in Alzheimer's disease
164. Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules
165. Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: Focusing on phosphatases
166. In vitro polymerization of oxidized tau into filaments
167. Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system
168. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5
169. Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay
170. The N-end rule
171. Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease
172. A protein kinase associated with paired helical filaments in Alzheimer disease
173. Increased production of paired helical filament epitopes in a cell culture system reduces the turnover of tau
174. Brain ubiquitin is markedly elevated in Alzheimer disease
175. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B
176. In vivo phosphorylation sites in fetal and adult rat tau
177. A protein factor essential for microtubule assembly
178. Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro
179. Polymerization of microtubule-associated protein tau under near-physiological conditions
180. Subunit structure of paired helical filaments in Alzheimer's disease
181. Structural characterization of the core of the paired helical filament of Alzheimer disease
182. Isolation of a fragment of tan derived from the core of the paired helical filament of Alzheimer disease
183. Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau
184. Dephosphorylation of microtubule proteins by brain protein phosphatases 1 and 2A, and its effect on microtubule assembly
185. Dephosphorylation of tau factor by protein phosphatase 2A in synaptosomal cytosol fractions, and inhibition by aluminum
186. Glycated tau protein in Alzheimer disease: A mechanism for induction of oxidant stress
187. Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments
188. Tau in paired helical filaments is functionally distinct from fetal tau: Assembly incompetence of paired helical filament-tau